Mark Edward Spring - 01 Nov 2025 Form 3 Insider Report for ARTELO BIOSCIENCES, INC. (ARTL)

Signature
/s/ Gregory D. Gorgas, as Attorney-in-Fact
Issuer symbol
ARTL
Transactions as of
01 Nov 2025
Net transactions value
$0
Form type
3
Filing time
17 Nov 2025, 17:30:44 UTC
Next filing
02 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Spring Mark Edward Chief Financial Officer C/O ARTELO BIOSCIENCES, INC.,, 505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH /s/ Gregory D. Gorgas, as Attorney-in-Fact 17 Nov 2025 0002091857

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARTL Stock Option (right to buy) 01 Nov 2025 Common Stock 5,000 $11.03 Direct F1
holding ARTL Stock Option (right to buy) 01 Nov 2025 Common Stock 2,500 $11.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date, such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. Vesting Commencement Date shall mean January 1, 2025.
F2 Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, fifty percent (50%) of the shares subject to the option shall vest January 1, 2026 and the remaining fifty percent (50%) of the shares subject to the option shall vest January 1, 2027.

Remarks:

Exhibit 24 - Power of Attorney